| Year |
Citation |
Score |
| 2023 |
Sparrow D, DeMolles D, Dubaz O, Durso R, Rosner B. Design issues in crossover trials involving patients with Parkinson's disease. Frontiers in Neurology. 14: 1197281. PMID 37670777 DOI: 10.3389/fneur.2023.1197281 |
0.347 |
|
| 2018 |
McNamara P, Durso R. The dopamine system, Parkinson's disease and language function Current Opinion in Behavioral Sciences. 21: 1-5. DOI: 10.1016/J.Cobeha.2017.10.010 |
0.399 |
|
| 2016 |
Morgan J, Clark D, Tripodis Y, Halloran CS, Minsky A, Wildman WJ, Durso R, McNamara P. Impacts of religious semantic priming on an intertemporal discounting task: Response time effects and neural correlates. Neuropsychologia. PMID 27450269 DOI: 10.1016/J.Neuropsychologia.2016.07.020 |
0.388 |
|
| 2016 |
Smart K, Durso R, Morgan J, McNamara P. A potential case of remission of Parkinson's disease. Journal of Complementary & Integrative Medicine. PMID 27379905 DOI: 10.1515/Jcim-2016-0019 |
0.497 |
|
| 2016 |
Harris E, McNamara P, Durso R. Possible selves in patients with right- versus left-onset Parkinson's disease. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 1-18. PMID 27141970 DOI: 10.1080/13825585.2016.1178211 |
0.421 |
|
| 2015 |
Harris E, McNamara P, Durso R. Novelty seeking in patients with right- versus left-onset Parkinson disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 28: 11-6. PMID 25812126 DOI: 10.1097/Wnn.0000000000000047 |
0.486 |
|
| 2014 |
Ratner MH, Farb DH, Ozer J, Feldman RG, Durso R. Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides. Interdisciplinary Toxicology. 7: 123-33. PMID 26109889 DOI: 10.2478/Intox-2014-0017 |
0.629 |
|
| 2013 |
Harris E, McNamara P, Durso R. Apathy in patients with Parkinson disease as a function of side of onset. Journal of Geriatric Psychiatry and Neurology. 26: 95-104. PMID 23584852 DOI: 10.1177/0891988713481267 |
0.538 |
|
| 2012 |
Modak A, Durso R, Josephs E, Rosen D. A rapid non invasive L-DOPA-¹³C breath test for optimally suppressing extracerebral AADC enzyme activity - toward individualizing carbidopa therapy in Parkinson’s disease. Journal of Parkinson's Disease. 2: 349-56. PMID 23646099 DOI: 10.3233/Jpd-012132 |
0.463 |
|
| 2011 |
Butler PM, McNamara P, Ghofrani J, Durso R. Disease-associated differences in religious cognition in patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 33: 917-28. PMID 21656414 DOI: 10.1080/13803395.2011.575768 |
0.581 |
|
| 2011 |
Butler PM, McNamara P, Durso R. Side of onset in Parkinson's disease and alterations in religiosity: novel behavioral phenotypes. Behavioural Neurology. 24: 133-41. PMID 21606574 DOI: 10.3233/Ben-2011-0282 |
0.464 |
|
| 2010 |
McNamara P, Stavitsky K, Durso R, Harris E. The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates. Parkinson's Disease. 2010. PMID 20948889 DOI: 10.4061/2010/263083 |
0.448 |
|
| 2010 |
McNamara P, Holtgraves T, Durso R, Harris E. Social cognition of indirect speech: Evidence from Parkinson's Disease. Journal of Neurolinguistics. 23: 162. PMID 20161657 DOI: 10.1016/J.Jneuroling.2009.12.003 |
0.548 |
|
| 2010 |
Butler PM, McNamara P, Durso R. Deficits in the automatic activation of religious concepts in patients with Parkinson's disease. Journal of the International Neuropsychological Society : Jins. 16: 252-61. PMID 19958570 DOI: 10.1017/S1355617709991202 |
0.507 |
|
| 2010 |
Holtgraves T, McNamara P, Cappaert K, Durso R. Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease. Brain and Cognition. 72: 189-96. PMID 19751960 DOI: 10.1016/J.Bandc.2009.08.004 |
0.323 |
|
| 2010 |
McNamara P, Stavitsky K, Harris E, Szent-Imrey O, Durso R. Mood, side of motor symptom onset and pain complaints in Parkinson's disease. International Journal of Geriatric Psychiatry. 25: 519-24. PMID 19711336 DOI: 10.1002/Gps.2374 |
0.487 |
|
| 2008 |
Stavitsky K, McNamara P, Durso R, Harris E, Auerbach S, Cronin-Golomb A. Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 21: 143-9. PMID 18797256 DOI: 10.1097/Wnn.0B013E318185E698 |
0.485 |
|
| 2008 |
McNamara P, Durso R, Harris E. Alterations of the sense of self and personality in Parkinson's disease. International Journal of Geriatric Psychiatry. 23: 79-84. PMID 17562520 DOI: 10.1002/Gps.1845 |
0.475 |
|
| 2007 |
McNamara P, Durso R, Harris E. "Machiavellianism" and frontal dysfunction: evidence from Parkinson's disease. Cognitive Neuropsychiatry. 12: 285-300. PMID 17558639 DOI: 10.1080/13546800701202316 |
0.571 |
|
| 2006 |
McNamara P, Durso R, Brown A. Religiosity in patients with Parkinson's disease. Neuropsychiatric Disease and Treatment. 2: 341-8. PMID 19412480 DOI: 10.2147/Nedt.2006.2.3.341 |
0.584 |
|
| 2006 |
McNamara P, Durso R, Harris E. Life goals of patients with Parkinson's disease: A pilot study on correlations with mood and cognitive functions. Clinical Rehabilitation. 20: 818-26. PMID 17005505 DOI: 10.1177/0269215506070811 |
0.434 |
|
| 2006 |
McNamara P, Durso R. Neuropharmacological treatment of mental dysfunction in Parkinson's disease. Behavioural Neurology. 17: 43-51. PMID 16720959 DOI: 10.1155/2006/138263 |
0.534 |
|
| 2005 |
Wegelin J, McNamara P, Durso R, Brown A, McLaren D. Correlates of excessive daytime sleepiness in Parkinson's disease. Parkinsonism & Related Disorders. 11: 441-8. PMID 16154796 DOI: 10.1016/J.Parkreldis.2005.05.007 |
0.527 |
|
| 2003 |
McNamara P, Durso R, Brown A. Relation of "Sense Of Self" to executive function performance in Parkinson's disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 16: 139-48. PMID 14501535 DOI: 10.1097/00146965-200309000-00001 |
0.434 |
|
| 2003 |
McNamara P, Durso R. Pragmatic communication skills in patients with Parkinson's disease. Brain and Language. 84: 414-23. PMID 12662979 DOI: 10.1016/S0093-934X(02)00558-8 |
0.522 |
|
| 2000 |
Durso R, Evans JE, Josephs E, Szabo G, Evans B, Fernandez HH, Browne TR. Variable absorption of carbidopa affects both peripheral and central levodopa metabolism. Journal of Clinical Pharmacology. 40: 854-60. PMID 10934669 DOI: 10.1177/00912700022009585 |
0.34 |
|
| 1998 |
Fernandez HH, Durso R. Clozapine for dopaminergic-induced paraphilias in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 597-8. PMID 9613761 DOI: 10.1002/Mds.870130338 |
0.507 |
|
| 1997 |
Durso R, Evans JE, Josephs E, Szabo GK, Evans BA, Handler JS, Jennings D, Browne TR. Central levodopa metabolism in Parkinson's disease after administration of stable isotope-labeled levodopa. Annals of Neurology. 42: 300-4. PMID 9307250 DOI: 10.1002/Ana.410420305 |
0.413 |
|
| 1997 |
Durso R. Chapter 17 Biotransformation and excretion: Quantitative studies of tissue metabolism Pharmacochemistry Library. 26: 315-335. DOI: 10.1016/S0165-7208(97)80164-X |
0.387 |
|
| 1996 |
McNamara P, Krueger M, O'Quin K, Clark J, Durso R. Grammaticality judgments and sentence comprehension in Parkinson's disease: a comparison with Broca's aphasia. The International Journal of Neuroscience. 86: 151-66. PMID 8828068 DOI: 10.3109/00207459608986706 |
0.549 |
|
| 1993 |
Durso R, Isaac K, Perry L, Saint-Hilaire M, Feldman RG. Age influences magnitude but not duration of response to levodopa. Journal of Neurology, Neurosurgery, and Psychiatry. 56: 65-8. PMID 8429325 |
0.586 |
|
| 1992 |
McNamara P, Obler LK, Au R, Durso R, Albert ML. Speech monitoring skills in Alzheimer's disease, Parkinson's disease, and normal aging. Brain and Language. 42: 38-51. PMID 1547468 DOI: 10.1016/0093-934X(92)90055-J |
0.393 |
|
| 1991 |
McNamara P, Durso R. Reversible pathologic jealousy (Othello syndrome) associated with amantadine. Journal of Geriatric Psychiatry and Neurology. 4: 157-9. PMID 1953968 DOI: 10.1177/089198879100400306 |
0.376 |
|
| 1990 |
Wolfe N, Katz DI, Albert ML, Almozlino A, Durso R, Smith MC, Volicer L. Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 53: 915-7. PMID 2266376 DOI: 10.1136/jnnp.53.10.915 |
0.35 |
|
| 1990 |
Saint-Hilaire M, Feldman RG, Durso R. Deprenyl for the treatment of early Parkinson's disease (IV) New England Journal of Medicine. 322: 1527. |
0.578 |
|
| 1989 |
Durso R, Szabo G, Davoudi H, Feldman RG. Magnitude of response to levodopa in Parkinson disease as it relates to peripheral and central measurements of levodopa and associated metabolites. Clinical Neuropharmacology. 12: 384-92. PMID 2611763 DOI: 10.1097/00002826-198910000-00003 |
0.534 |
|
| 1988 |
Rainero I, Kaye JA, May C, Durso R, Katz DI, Albert ML, Wolfe N, Pinessi L, Friedland RP, Rapoport SI. Alpha-melanocyte-stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease. Archives of Neurology. 45: 1224-7. PMID 2847695 DOI: 10.1001/Archneur.1988.00520350062017 |
0.405 |
|
| 1982 |
Tamminga CA, Durso R, Fedio P, Chase TN. Vasopressin studies in Alzheimer's disease Psychopharmacology Bulletin. 18: 48-49. |
0.301 |
|
| 1980 |
Lieberman AN, Kupersmith M, Neophytides A, Gopinathan G, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M. Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years. Advances in Biochemical Psychopharmacology. 23: 245-53. PMID 7395614 |
0.406 |
|
| 1980 |
Lieberman A, Kupersmith M, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Bear G, Goldstein M. Long-term efficacy of bromocriptine in Parkinson disease. Neurology. 30: 518-23. PMID 6768003 |
0.357 |
|
| 1979 |
Lieberman A, Kupersmith M, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Tartaro T. Bromocriptine mesylate in Parkinson's disease. New York State Journal of Medicine. 79: 1689-92. PMID 290866 |
0.435 |
|
| 1979 |
Lieberman A, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Tartaro T. Huntington's disease. New York State Journal of Medicine. 79: 1188-90. PMID 156887 |
0.333 |
|
| 1979 |
Lieberman A, Neophytides A, Kupersmith M, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M. Treatment of Parkinson's disease with dopamine agonists: a review. The American Journal of the Medical Sciences. 278: 65-76. PMID 39452 |
0.371 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1996 |
Folkerth RD, Durso R. Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology. 46: 1219-25. PMID 8628456 |
0.278 |
|
| 1983 |
Durso R, Tamminga CA, Ruggeri S, Denaro A, Kuo S, Chase TN. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 46: 1134-7. PMID 6229607 DOI: 10.1136/Jnnp.46.12.1134 |
0.276 |
|
| 2002 |
McNamara P, Durso R, Auerbach S. Dopaminergic syndromes of sleep, mood and mentation: Evidence from Parkinson's disease and related disorders Sleep and Hypnosis. 4: 119-131. |
0.26 |
|
| 1983 |
Durso R, Tamminga CA, Denaro A, Ruggeri S, Chase TN. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease. Neurology. 33: 1229-32. PMID 6225034 DOI: 10.1212/Wnl.33.9.1299 |
0.246 |
|
| 1996 |
Krengel M, White RF, Diamond R, Letz R, Cyrus P, Durso R. A comparison of NES2 and traditional neuropsychological tests in a neurologic patient sample. Neurotoxicology and Teratology. 18: 435-9. PMID 8866535 DOI: 10.1016/0892-0362(96)00022-0 |
0.242 |
|
| 1982 |
Durso R, Tamminga CA, Chase TN. Neuroendocrine defects in Huntington disease Neurology. 32: A 142. |
0.226 |
|
| 1988 |
Szabo GK, Davoudi H, Durso R. High-performance liquid chromatographic method for measuring homovanillic acid in cerebrospinal fluid using electrochemical detection with internal standardization. Journal of Chromatography. 430: 112-7. PMID 3215947 DOI: 10.1016/S0378-4347(00)83139-4 |
0.196 |
|
| 1982 |
Durso R, Fedio P, Brouwers P, Cox C, Martin AJ, Ruggieri SA, Tamminga CA, Chase TN. Lysine vasopressin in Alzheimer disease. Neurology. 32: 674-7. PMID 7201100 DOI: 10.1212/Wnl.32.6.674 |
0.191 |
|
| 2003 |
McNamara P, Durso R, Brown A, Lynch A. Counterfactual cognitive deficit in persons with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 1065-70. PMID 12876235 DOI: 10.1136/Jnnp.74.8.1065 |
0.184 |
|
| 1982 |
LeWitt PA, Gopinathan G, Ward CD, Sanes JN, Dambrosia JM, Durso R, Calne DB. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study. Neurology. 32: 69-72. PMID 7033825 DOI: 10.1212/WNL.32.1.69 |
0.183 |
|
| 1990 |
Fazzini E, Durso R, Davoudi H, Szabo GK, Albert ML. GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice. Journal of the Neurological Sciences. 99: 59-68. PMID 2250172 DOI: 10.1016/0022-510X(90)90199-W |
0.132 |
|
| 2005 |
Michaelides C, Thakore-James M, Durso R. Reversible withdrawal dyskinesia associated with quetiapine. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 769-70. PMID 15747370 DOI: 10.1002/mds.20427 |
0.097 |
|
| 2013 |
Slovin SF, Kehoe M, Durso R, Fernandez C, Olson W, Gao JP, Israel R, Scher HI, Morris S. A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer. Vaccine. 31: 943-9. PMID 23246260 DOI: 10.1016/j.vaccine.2012.11.096 |
0.092 |
|
| 2018 |
Durso R, Craig Jenkins J, Martin A, Stearmer M. How to study political activists: A petition survey approach. Social Science Research. 73: 207-220. PMID 29793687 DOI: 10.1016/j.ssresearch.2018.03.014 |
0.074 |
|
| 2005 |
Gardner JP, Durso RJ, Jacques S, Arrigale R, Maughan M, Donovan GP, Schülke N, Israel RJ, Olson WC. Novel prime-boost combinations of PSMA-based vaccines for prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2572. PMID 27945866 DOI: 10.1200/jco.2005.23.16_suppl.2572 |
0.061 |
|
| 1991 |
Bartoletti JR, West DJ, Patterson RC, Durso RG, Powell LJ, Fisher JD. Evolution of power management systems for the 1990's 1991 Ieee Industry Application Society Annual Meeting. 1780-1787. |
0.055 |
|
| 2001 |
Stitzel ML, Durso R, Reese JC. The proteasome regulates the UV-induced activation of the AP-1-like transcription factor Gcn4. Genes & Development. 15: 128-33. PMID 11157770 DOI: 10.1101/Gad.863801 |
0.053 |
|
| 2024 |
Monaghan SA, Eck S, Bunting S, Dong XX, Durso RJ, Gonneau C, Hays A, Illingworth A, League SC, Linskens E, McCausland M, McCloskey TW, Rolf N, Shi M, Wallace PK, et al. Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines. Cytometry. Part B, Clinical Cytometry. PMID 39165120 DOI: 10.1002/cyto.b.22202 |
0.048 |
|
| 2013 |
Durso RM, Jacobs D. The determinants of the number of white supremacist groups: A pooled time-series analysis Social Problems. 60: 128-144. DOI: 10.1525/sp.2013.10168 |
0.041 |
|
| 2004 |
Cormier EG, Durso RJ, Tsamis F, Boussemart L, Manix C, Olson WC, Gardner JP, Dragic T. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America. 101: 14067-72. PMID 15371595 DOI: 10.1073/pnas.0405695101 |
0.04 |
|
| 2009 |
Banerjee K, Andjelic S, Klasse PJ, Kang Y, Sanders RW, Michael E, Durso RJ, Ketas TJ, Olson WC, Moore JP. Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo. Virology. 389: 108-21. PMID 19410272 DOI: 10.1016/j.virol.2009.04.001 |
0.037 |
|
| 2011 |
Slovin SF, Morris S, Kargman M, Durso R, Curley T, Israel RJ, Olson WC, Murphy D, Scher HI. A phase I dose-escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Final results. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e15170. PMID 28020917 DOI: 10.1200/jco.2011.29.15_suppl.e15170 |
0.035 |
|
| 2001 |
Durso RJ, Fisher AK, Albright-Frey TJ, Reese JC. Analysis of TAF90 mutants displaying allele-specific and broad defects in transcription. Molecular and Cellular Biology. 21: 7331-44. PMID 11585915 DOI: 10.1128/Mcb.21.21.7331-7344.2001 |
0.034 |
|
| 2004 |
Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America. 101: 7270-4. PMID 15123813 DOI: 10.1073/pnas.0402253101 |
0.034 |
|
| 2003 |
Gardner JP, Durso RJ, Arrigale RR, Donovan GP, Maddon PJ, Dragic T, Olson WC. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America. 100: 4498-503. PMID 12676990 DOI: 10.1073/pnas.0831128100 |
0.031 |
|
| 2009 |
Kang YK, Andjelic S, Binley JM, Crooks ET, Franti M, Iyer SP, Donovan GP, Dey AK, Zhu P, Roux KH, Durso RJ, Parsons TF, Maddon PJ, Moore JP, Olson WC. Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. Vaccine. 27: 5120-32. PMID 19567243 DOI: 10.1016/J.Vaccine.2009.06.037 |
0.029 |
|
| 2011 |
Slovin SF, Kargman M, Durso R, Curley T, Israel RJ, Olson WC, Morris S, Murphy D, Scher HI. A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 140. PMID 27968578 DOI: 10.1200/Jco.2011.29.7_Suppl.140 |
0.026 |
|
| 2007 |
Durso RJ, Andjelic S, Gardner JP, Margitich DJ, Donovan GP, Arrigale RR, Wang X, Maughan MF, Talarico TL, Olmsted RA, Heston WD, Maddon PJ, Olson WC. A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3999-4008. PMID 17606734 DOI: 10.1158/1078-0432.CCR-06-2202 |
0.026 |
|
| 2006 |
Falkowska E, Durso RJ, Gardner JP, Cormier EG, Arrigale RA, Ogawa RN, Donovan GP, Maddon PJ, Olson WC, Dragic T. L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles. The Journal of General Virology. 87: 2571-6. PMID 16894195 DOI: 10.1099/vir.0.82034-0 |
0.019 |
|
| 2013 |
Aponte J, Cruz H, Arce S, Durso RM. Partnership among a faith-based organization and community. Holistic Nursing Practice. 27: 162-7. PMID 23580102 DOI: 10.1097/HNP.0b013e31828a099a |
0.01 |
|
| Hide low-probability matches. |